4//SEC Filing
Davis Thomas Andrew 4
Accession 0001457612-22-000028
CIK 0001457612other
Filed
Mar 16, 8:00 PM ET
Accepted
Mar 17, 4:09 PM ET
Size
8.8 KB
Accession
0001457612-22-000028
Insider Transaction Report
Form 4
Davis Thomas Andrew
CHIEF MEDICAL OFFICER
Transactions
- Award
Common Stock
2022-03-15+31,250→ 72,138 total - Sale
Common Stock
2022-03-16$1.10/sh−2,717$2,989→ 69,421 total - Award
Stock Option (Right to Buy)
2022-03-15+93,750→ 93,750 totalExercise: $1.11Exp: 2032-03-15→ Common Stock (93,750 underlying)
Footnotes (3)
- [F1]Restricted stock units that represent the contingent right to receive, at settlement, one share of common stock. The restricted stock units are scheduled to vest 25% on each of the first four anniversaries of the grant date.
- [F2]Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person.
- [F3]The options are scheduled to vest in 48 equal monthly installments beginning on the first monthly anniversary of the grant date.
Documents
Issuer
GENOCEA BIOSCIENCES, INC.
CIK 0001457612
Entity typeother
Related Parties
1- filerCIK 0001338185
Filing Metadata
- Form type
- 4
- Filed
- Mar 16, 8:00 PM ET
- Accepted
- Mar 17, 4:09 PM ET
- Size
- 8.8 KB